Barclays began coverage on shares of Aveanna Healthcare (NASDAQ:AVAH - Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm issued an equal weight rating and a $5.50 price target on the stock.
A number of other research analysts have also issued reports on AVAH. Wall Street Zen lowered shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 27th. UBS Group boosted their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research report on Friday, May 9th. Finally, Truist Financial lowered their target price on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research report on Friday, April 11th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, Aveanna Healthcare presently has an average rating of "Hold" and an average price target of $5.20.
Read Our Latest Stock Report on Aveanna Healthcare
Aveanna Healthcare Price Performance
Shares of NASDAQ AVAH traded up $0.17 during mid-day trading on Wednesday, hitting $4.63. The company had a trading volume of 480,689 shares, compared to its average volume of 342,245. Aveanna Healthcare has a 12 month low of $2.48 and a 12 month high of $6.19. The stock has a market cap of $902.29 million, a price-to-earnings ratio of 231.25 and a beta of 1.98. The firm's 50 day simple moving average is $5.16 and its two-hundred day simple moving average is $4.87.
Insider Activity at Aveanna Healthcare
In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 750,000 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the sale, the insider directly owned 28,890,756 shares in the company, valued at $150,231,931.20. This trade represents a 2.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, major shareholder Paul R. Vigano sold 750,000 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the completion of the sale, the insider owned 28,890,756 shares in the company, valued at approximately $150,231,931.20. This represents a 2.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,115,345 shares of company stock worth $37,838,057 in the last 90 days. Insiders own 7.80% of the company's stock.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. First Eagle Investment Management LLC bought a new stake in Aveanna Healthcare during the 4th quarter worth about $1,992,000. Nuveen LLC bought a new position in shares of Aveanna Healthcare in the 1st quarter valued at about $1,692,000. Millennium Management LLC grew its position in shares of Aveanna Healthcare by 105.0% during the 4th quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after buying an additional 205,023 shares during the period. Jacobs Levy Equity Management Inc. grew its position in shares of Aveanna Healthcare by 50.1% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after buying an additional 177,856 shares during the period. Finally, Mackenzie Financial Corp raised its stake in shares of Aveanna Healthcare by 145.9% during the first quarter. Mackenzie Financial Corp now owns 263,662 shares of the company's stock worth $1,429,000 after buying an additional 156,439 shares during the last quarter. 87.96% of the stock is owned by institutional investors.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
See Also

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.